Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Allergan

    Tag: allergan

    You Searched For "Allergan"
    AbbVie says multiple parties vying for assets related to Allergan deal approval

    AbbVie says multiple parties vying for assets related to Allergan deal approval

    Medical Dialogues Bureau4 Nov 2019 9:00 AM IST
    AbbVie Inc said it had notified the U.S. antitrust watchdog of its intention to divest its experimental inflammatory bowel disease therapy,...
    Allergan shareholders okays USD 63 billion AbbVie acquisition

    Allergan shareholders okays USD 63 billion AbbVie acquisition

    Medical Dialogues Bureau15 Oct 2019 9:30 AM IST
    Under the terms of the agreement announced on June 25, 2019, AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity...
    Everstone-backed Everlife names Raman Gandotra as new CEO

    Everstone-backed Everlife names Raman Gandotra as new CEO

    Medical Dialogues Bureau15 Sept 2019 9:00 AM IST
    Prior to joining Everlife, Raman Gandotra was leading the India and South-East Asia business of Smith & Nephew, Baxter and Allergan.New Delhi:...
    Allergan, Endo agree to USD 15 million settlement in major opioid case

    Allergan, Endo agree to USD 15 million settlement in major opioid case

    Medical Dialogues Bureau24 Aug 2019 9:00 AM IST
    Allergan has tentatively agreed to pay $5 million to resolve claims involving its branded opioids, though the deal does not resolve claims involving...
    AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year

    AbbVie wins USFDA nod for new rheumatoid arthritis drug priced at Rs 41 lakh per year

    Medical Dialogues Bureau18 Aug 2019 9:36 AM IST
    A four-week supply of Humira, the world's best-selling medicine, has a list price of about $5,174, amounting to more than $60,000 for a year.U.S:...
    Allergan announces worldwide recall of textured breast implant tied to rare cancer

    Allergan announces worldwide recall of textured breast implant tied to rare cancer

    Medical Dialogues Bureau26 July 2019 9:15 AM IST
    The U.S. Food and Drug Administration said it called for the removal after new information showed Allergan Inc's Biocell breast implants account for a...
    Abbvie finalizes deal to buy Botox maker Allergan for $63 billion

    Abbvie finalizes deal to buy Botox maker Allergan for $63 billion

    Medical Dialogues Bureau26 Jun 2019 10:00 AM IST
    A note from Moody's affirmed Abbvie's debt rating, saying a plan to reduce debt through existing blockbusters like AbbVie's Humira and Imbruvica and...
    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Farhat Nasim15 April 2019 10:05 AM IST
    Bimatoprost Ophthalmic Solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...
    USFDA accepts Allergan license applications to expand Botox label

    USFDA accepts Allergan license applications to expand Botox label

    Farhat Nasim11 March 2019 9:30 AM IST
    "The FDA's acceptance of Allergan's supplemental biologics license applications is a monumental milestone on our journey to bring new treatment...
    Allergan depression drug fails trial, loses over Rs 100 crore expected sales

    Allergan depression drug fails trial, loses over Rs 100 crore expected sales

    Farhat Nasim8 March 2019 9:00 AM IST
    Stanicky said the data was the most anticipated release of the year and likely means that Allergan will lose what had been expected to be a $1 billion...
    Health Canada places restrictions on Allergan Fibroid treatment Esmya

    Health Canada places restrictions on Allergan Fibroid treatment Esmya

    Farhat Nasim13 Jan 2019 9:00 AM IST
    The drug is sold in Europe by Hungarian drugmaker Richter. Richter has said it considered Esmya to be a safe and effective form of treatment.Canada:...
    Pfizer loses blockbuster Epilepsy drug patent fight in UK Supreme Court

    Pfizer loses blockbuster Epilepsy drug patent fight in UK Supreme Court

    Medical Dialogues Bureau15 Nov 2018 11:42 AM IST
    The expiry of the basic patent on Lyrica five years ago had allowed generic drugmakers to launch cut-price versions of Pfizer's medicine, which...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok